Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	single-stranded telomeric DNA binding	HNRNPA1L2 HNRNPA1 HNRNPA2B1 STN1	6.13e-06	13	197	4	GO:0043047
GeneOntologyMolecularFunction	sequence-specific single stranded DNA binding	HNRNPA1L2 HNRNPA1 HNRNPA2B1 STN1	1.15e-05	15	197	4	GO:0098847
GeneOntologyMolecularFunction	small GTPase binding	NCKAP1 ALS2CL GDI1 GDI2 RBSN SRGAP1 RHOBTB3 RAPGEF4 SRGAP2 RAB11FIP5 DGKI DEPDC5 IPO11	1.92e-05	321	197	13	GO:0031267
GeneOntologyMolecularFunction	telomeric DNA binding	HNRNPA1L2 HNRNPA1 HNRNPA2B1 STN1 PURA	4.42e-05	40	197	5	GO:0042162
GeneOntologyMolecularFunction	GTPase binding	NCKAP1 ALS2CL GDI1 GDI2 RBSN SRGAP1 RHOBTB3 RAPGEF4 SRGAP2 RAB11FIP5 DGKI DEPDC5 IPO11	6.27e-05	360	197	13	GO:0051020
GeneOntologyMolecularFunction	N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity	B4GALNT3 B4GALNT4	9.68e-05	2	197	2	GO:0033842
GeneOntologyMolecularFunction	Rab GDP-dissociation inhibitor activity	GDI1 GDI2	9.68e-05	2	197	2	GO:0005093
GeneOntologyMolecularFunction	G-rich strand telomeric DNA binding	HNRNPA1L2 HNRNPA1 HNRNPA2B1	1.47e-04	11	197	3	GO:0098505
GeneOntologyMolecularFunction	poly(A) RNA polymerase activity	TENT5C TENT5A TENT5B	1.95e-04	12	197	3	GO:1990817
GeneOntologyMolecularFunction	nucleocytoplasmic carrier activity	KPNA6 KPNA1 NUP214 IPO11	2.66e-04	32	197	4	GO:0140142
GeneOntologyMolecularFunction	telomeric repeat-containing RNA binding	HNRNPA1L2 HNRNPA1	2.89e-04	3	197	2	GO:0061752
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH5 DNAH6 DNAH10	6.92e-04	18	197	3	GO:0008569
GeneOntologyMolecularFunction	17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity	AKR1C4 HSD17B2	9.50e-04	5	197	2	GO:0047006
GeneOntologyMolecularFunction	RNA strand annealing activity	HNRNPA1L2 HNRNPA1	9.50e-04	5	197	2	GO:0033592
GeneOntologyMolecularFunction	nuclear import signal receptor activity	KPNA6 KPNA1 IPO11	9.53e-04	20	197	3	GO:0061608
GeneOntologyCellularComponent	catalytic step 2 spliceosome	HNRNPA1L2 HNRNPA1L3 HNRNPA1 HNRNPA2B1 XAB2 PPIL3 SF3B2	4.37e-05	97	202	7	GO:0071013
GeneOntologyCellularComponent	glutamatergic synapse	MYO9A CHD4 ADAM10 TENM2 HNRNPA2B1 PPM1H NRP2 SRGAP2C PURA RNF216 DLG2 AKT1 BSN CNTN1 KPNA1 RASGRF2 VEZT RAPGEF4 SRGAP2 DGKI SRGAP2B	4.57e-05	817	202	21	GO:0098978
GeneOntologyCellularComponent	spliceosomal complex	HNRNPA1L2 HNRNPA1L3 HNRNPA1 HNRNPA2B1 XAB2 PPIL3 SF3B2 CWF19L1 RBM41	2.53e-04	215	202	9	GO:0005681
Domain	-	B4GALNT3 B4GALNT4 PKHD1L1	1.17e-06	3	198	3	3.90.182.10
Domain	PA14	B4GALNT3 B4GALNT4 PKHD1L1	1.17e-06	3	198	3	SM00758
Domain	PA14	B4GALNT3 B4GALNT4 PKHD1L1	1.17e-06	3	198	3	PF07691
Domain	PA14_dom	B4GALNT3 B4GALNT4 PKHD1L1	1.17e-06	3	198	3	IPR011658
Domain	HnRNPA1	HNRNPA1L2 HNRNPA1 HNRNPA2B1	1.17e-06	3	198	3	IPR021662
Domain	HnRNPA1	HNRNPA1L2 HNRNPA1 HNRNPA2B1	1.17e-06	3	198	3	PF11627
Domain	srGAP2	SRGAP2C SRGAP2 SRGAP2B	1.17e-06	3	198	3	IPR030252
Domain	FCH	FCHSD2 SRGAP2C SRGAP1 SRGAP2 SRGAP2B	2.90e-06	22	198	5	PF00611
Domain	FCH	FCHSD2 SRGAP2C SRGAP1 SRGAP2 SRGAP2B	2.90e-06	22	198	5	SM00055
Domain	FCH_dom	FCHSD2 SRGAP2C SRGAP1 SRGAP2 SRGAP2B	3.67e-06	23	198	5	IPR001060
Domain	DUF1693	TENT5C TENT5A TENT5B	4.66e-06	4	198	3	IPR012937
Domain	DUF1908	MAST2 MAST4 MAST3	4.66e-06	4	198	3	PF08926
Domain	MA_Ser/Thr_Kinase_dom	MAST2 MAST4 MAST3	4.66e-06	4	198	3	IPR015022
Domain	DUF1693	TENT5C TENT5A TENT5B	4.66e-06	4	198	3	SM01153
Domain	NTP_transf_7	TENT5C TENT5A TENT5B	4.66e-06	4	198	3	PF07984
Domain	MAST_pre-PK_dom	MAST2 MAST4 MAST3	4.66e-06	4	198	3	IPR023142
Domain	-	MAST2 MAST4 MAST3	4.66e-06	4	198	3	1.20.1480.20
Domain	F_BAR	FCHSD2 SRGAP2C SRGAP1 SRGAP2 SRGAP2B	5.69e-06	25	198	5	IPR031160
Domain	F_BAR	FCHSD2 SRGAP2C SRGAP1 SRGAP2 SRGAP2B	5.69e-06	25	198	5	PS51741
Domain	TPR-like_helical_dom	TMTC2 PSMD11 TTC9C XAB2 TONSL P4HA2 USP28 WDR19 NPHP3 RMDN1 EMC2 CDC23	7.50e-06	233	198	12	IPR011990
Domain	TPR_REGION	TMTC2 TTC9C TONSL P4HA2 DNAH10 WDR19 NPHP3 RMDN1 EMC2 CDC23	1.07e-05	165	198	10	PS50293
Domain	TPR	TMTC2 TTC9C TONSL P4HA2 DNAH10 WDR19 NPHP3 RMDN1 EMC2 CDC23	1.07e-05	165	198	10	PS50005
Domain	-	TMTC2 PSMD11 TTC9C XAB2 TONSL P4HA2 WDR19 NPHP3 RMDN1 EMC2 CDC23	1.35e-05	207	198	11	1.25.40.10
Domain	TPR-contain_dom	TMTC2 TTC9C XAB2 TONSL P4HA2 WDR19 NPHP3 EMC2 CDC23	3.23e-05	150	198	9	IPR013026
Domain	TPR_repeat	TMTC2 TTC9C XAB2 TONSL P4HA2 NPHP3 EMC2 CDC23	8.76e-05	133	198	8	IPR019734
Domain	P-loop_NTPase	MYO1G MYO9A CHD4 SRCAP SEPTIN1 DLG2 DNAH5 DNAH6 MOV10 DNAH10 GAL3ST1 RHOBTB3 APAF1 ABCC5 RNF213 FANCM NPHP3 TJP1 GPN2 ABCC12 CTPS1 HYDIN	1.00e-04	848	198	22	IPR027417
Domain	RabGDI	GDI1 GDI2	1.12e-04	2	198	2	IPR000806
Domain	TPR_2	TMTC2 TTC9C XAB2 P4HA2 NPHP3	1.83e-04	50	198	5	PF07719
Domain	TPR_2	TMTC2 TTC9C XAB2 P4HA2 NPHP3	1.83e-04	50	198	5	IPR013105
Domain	AGC-kinase_C	MAST2 MAST4 AKT1 PRKG1 MAST3	3.14e-04	56	198	5	IPR000961
Domain	AGC_KINASE_CTER	MAST2 MAST4 AKT1 PRKG1 MAST3	3.14e-04	56	198	5	PS51285
Domain	S_TK_X	MAST2 MAST4 AKT1 PRKG1 MAST3	3.14e-04	56	198	5	SM00133
Domain	TSNAXIP1_N	CLHC1 C6orf118	3.33e-04	3	198	2	IPR032755
Domain	TSNAXIP1_N	CLHC1 C6orf118	3.33e-04	3	198	2	PF15739
Domain	-	CHD4 SRCAP SEPTIN1 DLG2 DNAH5 DNAH6 MOV10 DNAH10 RHOBTB3 APAF1 ABCC5 RNF213 FANCM NPHP3 TJP1 GPN2 ABCC12 CTPS1 HYDIN	3.82e-04	746	198	19	3.40.50.300
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DNAH6 DNAH10	3.92e-04	14	198	3	IPR024317
Domain	Dynein_HC_stalk	DNAH5 DNAH6 DNAH10	3.92e-04	14	198	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH5 DNAH6 DNAH10	3.92e-04	14	198	3	IPR013602
Domain	DHC_N2	DNAH5 DNAH6 DNAH10	3.92e-04	14	198	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH5 DNAH6 DNAH10	3.92e-04	14	198	3	IPR011704
Domain	MT	DNAH5 DNAH6 DNAH10	3.92e-04	14	198	3	PF12777
Domain	AAA_8	DNAH5 DNAH6 DNAH10	3.92e-04	14	198	3	PF12780
Domain	AAA_5	DNAH5 DNAH6 DNAH10	3.92e-04	14	198	3	PF07728
Domain	TPR	TMTC2 TTC9C XAB2 TONSL NPHP3 EMC2 CDC23	4.55e-04	129	198	7	SM00028
Domain	DHC_fam	DNAH5 DNAH6 DNAH10	4.86e-04	15	198	3	IPR026983
Domain	Dynein_heavy	DNAH5 DNAH6 DNAH10	4.86e-04	15	198	3	PF03028
Domain	Dynein_heavy_dom	DNAH5 DNAH6 DNAH10	4.86e-04	15	198	3	IPR004273
Domain	PINT	EIF3E PSMD11 PSMD13	5.94e-04	16	198	3	SM00088
Domain	G8_domain	PKHD1 PKHD1L1	6.62e-04	4	198	2	IPR019316
Domain	G8	PKHD1 PKHD1L1	6.62e-04	4	198	2	PS51484
Domain	G8	PKHD1 PKHD1L1	6.62e-04	4	198	2	SM01225
Domain	GDI	GDI1 GDI2	6.62e-04	4	198	2	PF00996
Domain	G8	PKHD1 PKHD1L1	6.62e-04	4	198	2	PF10162
Domain	GDP_dissociation_inhibitor	GDI1 GDI2	6.62e-04	4	198	2	IPR018203
Domain	PCI_dom	EIF3E PSMD11 PSMD13	7.15e-04	17	198	3	IPR000717
Domain	PCI	EIF3E PSMD11 PSMD13	7.15e-04	17	198	3	PF01399
Domain	SPIN/Ssty	SPIN4 SPIN3	1.09e-03	5	198	2	IPR003671
Domain	Spin-Ssty	SPIN4 SPIN3	1.09e-03	5	198	2	PF02513
Domain	PbH1	PKHD1 PKHD1L1	1.63e-03	6	198	2	SM00710
Domain	Haem_d1	EML6 WDR19	1.63e-03	6	198	2	IPR011048
Domain	PbH1	PKHD1 PKHD1L1	1.63e-03	6	198	2	IPR006626
Domain	Arm_3	KPNA6 KPNA1	2.27e-03	7	198	2	PF16186
Domain	Importing_su_alpha	KPNA6 KPNA1	2.27e-03	7	198	2	IPR024931
Domain	IBB	KPNA6 KPNA1	2.27e-03	7	198	2	PF01749
Domain	Arm_3	KPNA6 KPNA1	2.27e-03	7	198	2	IPR032413
Domain	TPR_8	TMTC2 XAB2 TONSL CDC23	2.39e-03	53	198	4	PF13181
Pathway	REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	PSMD1 KPNA6 PSMD11 PSMD13 KPNA1 PSMF1 CDC23	1.86e-05	81	144	7	MM15360
Pathway	REACTOME_DNA_REPLICATION	PSMD1 KPNA6 PSMD11 PSMD13 KPNA1 PSMF1 LIG1 CDC23	4.19e-05	125	144	8	MM15380
Pathway	REACTOME_DNA_REPLICATION_PRE_INITIATION	PSMD1 KPNA6 PSMD11 PSMD13 KPNA1 PSMF1 CDC23	5.98e-05	97	144	7	MM15369
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	HGF PDGFRB PSMD1 CHD4 PSMD11 PSMD13 CHUK AKT1 FGFR3 MOV10 PSMF1 PPARG	8.81e-05	313	144	12	M27867
Pathway	REACTOME_PTEN_REGULATION	PSMD1 CHD4 PSMD11 PSMD13 AKT1 MOV10 PSMF1 PPARG	8.91e-05	139	144	8	M27646
Pathway	REACTOME_APOPTOSIS	PSMD1 PSMD11 PSMD13 AKT1 KPNA1 PSMF1 APAF1 TJP1 CLSPN	9.18e-05	179	144	9	M15303
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH5 DNAH6 DNAH10 ACTR1A	1.53e-04	27	144	4	M47755
Pathway	REACTOME_SIGNALING_BY_NOTCH4	PSMD1 PSMD11 PSMD13 ADAM10 AKT1 PSMF1	1.89e-04	82	144	6	M594
Pathway	REACTOME_SIGNALING_BY_NOTCH	HDAC9 PSMD1 PSMD11 PSMD13 ADAM10 AKT1 WWC1 MOV10 CNTN1 PSMF1	2.17e-04	246	144	10	M10189
Pathway	REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING	PSMD1 PSMD11 PSMD13 AKT1 PSMF1	2.19e-04	54	144	5	M27931
Pathway	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	PSMD1 PSMD11 PSMD13 AKT1 PSMF1 NUP214	2.46e-04	86	144	6	MM15140
Pathway	REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING	PSMD1 PSMD11 PSMD13 CHUK PSMF1	2.61e-04	56	144	5	MM15203
Pathway	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	PSMD1 PSMD11 PSMD13 AKT1 PSMF1 NUP214	2.62e-04	87	144	6	M944
Pathway	REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS	HGF PDGFRB PSMD1 CHD4 PSMD11 PSMD13 CHUK AKT1 FGFR3 PSMF1	2.63e-04	252	144	10	MM15585
Pathway	REACTOME_PROGRAMMED_CELL_DEATH	PSMD1 PSMD11 PSMD13 AKT1 KPNA1 PSMF1 APAF1 TJP1 CLSPN	3.16e-04	211	144	9	M27436
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCKAP1 CHD4 LMTK3 EPB41L3 GDI1 GDI2 TENM2 PPM1H ZNF462 SSH1 PURA DLG2 BSN CNTN1 KPNA1 USP28 RAPGEF4 SRGAP2 ACTR1A PBRM1 TJP1 DGKI AFF4	1.17e-08	963	202	23	28671696
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	NCKAP1 PDGFRB EIF3E PSMD1 KPNA6 CHD4 PSMD11 PSMD13 EPB41L3 MAST2 GDI2 HNRNPA1 PGD HNRNPA2B1 SUPT6H BSN DNAH5 SF3B2 MARS2 DNAH10 APOB NUP214 NMD3 ACTR1A NAMPT PBRM1 EMC2 CTPS1	1.85e-08	1425	202	28	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NCKAP1 MYO9A HNRNPA1L2 EPB41L3 CMAS GDI1 GDI2 HNRNPA1 HNRNPA2B1 PTGS2 PURA PYGB DLG2 BSN DNAH6 HSDL1 CNTN1 GPC1 DPP6 KRT78 RAPGEF4 SRGAP2 ELP3 NT5DC3 ACTR1A GUCY1A2 TJP1 CACNA2D3	2.03e-08	1431	202	28	37142655
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	NCKAP1 EIF3E CHD4 PSMD11 PSMD13 EPB41L3 CMAS GDI1 GDI2 HNRNPA1 PGD HNRNPA2B1 XAB2 KRT80 PYGB SF3B2 PSMF1 KRT78 RNF213 NUP214 ACTR1A NAMPT TJP1 RMDN1 CTPS1 IPO11	1.19e-07	1367	202	26	32687490
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HDAC9 PDGFRB PSMD1 KPNA6 CHD4 CMAS GDI1 XAB2 CHUK RNF216 DLG2 SF3B2 KPNA1 AKAP6 VPS39 USP28 RHOBTB3 RAPGEF4 LAMB1 ABCC5 SRGAP2 KRIT1 WDR19 TJP1 AFF4	1.39e-07	1285	202	25	35914814
Pubmed	Inhibition of SRGAP2 function by its human-specific paralogs induces neoteny during spine maturation.	SRGAP2C SRGAP2 SRGAP2B	1.93e-07	3	202	3	22559944
Pubmed	A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1.	HNRNPA1L2 HNRNPA1 HNRNPA2B1	1.93e-07	3	202	3	27151978
Pubmed	Phosphomimetic substitution of heterogeneous nuclear ribonucleoprotein A1 at serine 199 abolishes AKT-dependent internal ribosome entry site-transacting factor (ITAF) function via effects on strand annealing and results in mammalian target of rapamycin complex 1 (mTORC1) inhibitor sensitivity.	HNRNPA1L2 HNRNPA1 AKT1	1.93e-07	3	202	3	21454539
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	NCKAP1 ADAM7 EIF3E PSMD1 CHD4 AKR1C4 PSMD13 GDI1 GDI2 HNRNPA1 PGD HNRNPA2B1 NRP2 PYGB RIPOR1 TRPM1 MOV10 GPC1 CTPS1	2.72e-07	803	202	19	36517590
Pubmed	Defining the membrane proteome of NK cells.	MYO1G HGF PDGFRB EIF3E PSMD1 KPNA6 CHD4 PSMD11 PSMD13 CMAS ADAM10 HNRNPA1 HNRNPA2B1 XAB2 PYGB PSMF1 RNF213 ENPP4 NMD3 PIGT GYS1 LRRC8A CTPS1	3.71e-07	1168	202	23	19946888
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	EIF3E CHD4 GDI2 PGD SPIN4 HNRNPA2B1 SUPT6H RIPOR1 SF3B2 WWC1 MOV10 KPNA1 VPS39 TENT5A LAMB1 APOB NUP214 CTPS1	5.01e-07	754	202	18	35906200
Pubmed	Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication.	SRGAP2C SRGAP2 SRGAP2B	7.69e-07	4	202	3	22559943
Pubmed	Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.	HNRNPA1L2 HNRNPA1 HNRNPA2B1	7.69e-07	4	202	3	12426391
Pubmed	Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells.	PTGS2 AKT1 APAF1	7.69e-07	4	202	3	22335196
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	NCKAP1 MYO9A EIF3E PSMD1 CHD4 PSMD11 PSMD13 SRCAP EPB41L3 CMAS HNRNPA1 PGD HNRNPA2B1 PYGB SF3B2 MOV10 KPNA1 GPC1 NUP214 ELP3 NMD3 ACTR1A NAMPT CTPS1	1.30e-06	1353	202	24	29467282
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HDAC9 ZCCHC2 EPB41L3 ZNF462 SSH1 MOV10 MAN2B2 RNF213 ENPP4 FANCM NPHP3 EMC2 MBD5 MAST3	1.33e-06	493	202	14	15368895
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NCKAP1 KPNA6 PSMD13 EPB41L3 SEPTIN1 COL6A6 RASGRF2 RAPGEF4 NUP214 RP1 CTPS1 HYDIN CDC23 IPO11	1.46e-06	497	202	14	36774506
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NCKAP1 EIF3E PSMD1 CHD4 EPB41L3 GDI1 GDI2 XAB2 SUPT6H PYGB SF3B2 MOV10 BEND3 NUP214 PBRM1 TJP1	1.58e-06	653	202	16	22586326
Pubmed	Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling.	HNRNPA1L2 HNRNPA1 AKT1	1.91e-06	5	202	3	18562319
Pubmed	The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism.	HNRNPA1L2 HNRNPA1 HNRNPA2B1	1.91e-06	5	202	3	20133837
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	CHD4 USP27X USP22 VPS39 USP28 ACTR1A TJP1 DEPDC5	2.52e-06	147	202	8	29576527
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	KPNA6 SRCAP HNRNPA1 HNRNPA2B1 SUPT6H PURA SF3B2 MOV10 KPNA1 CCDC87 AFF4 IPO11	3.42e-06	390	202	12	17643375
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ADAM7 EML6 PSMD1 CHD4 HNRNPA1L2 SRCAP EPB41L3 HNRNPA1 HNRNPA2B1 CHUK C6orf118 PKHD1 DLG2 PPIP5K2 BSN DNAH6 PCDHGA10 RDH12 ABCC5 BEND3 APOB GUCY1A2 TJP1 EMC2	3.86e-06	1442	202	24	35575683
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	MYO9A GDI1 PKHD1 TRPM1 BSN DNAH5 KRT78 RNF213 RP1	3.92e-06	208	202	9	33230847
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	HNRNPA1L2 PSMD13 EPB41L3 CMAS GDI1 GDI2 HNRNPA1 PGD HNRNPA2B1 PURA PYGB CALB2 RDH12 ACTR1A	4.89e-06	552	202	14	36293380
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	NCKAP1 EIF3E PSMD1 KPNA6 PSMD11 PSMD13 EPB41L3 MAST2 GDI1 PURA TONSL HSDL1 SF3B2 MOV10 KPNA1 KRT78 RASGRF2 SRGAP2 VAC14 GYS1 CTPS1 IPO11	6.40e-06	1284	202	22	17353931
Pubmed	HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.	HNRNPA1L2 HNRNPA1 HNRNPA2B1	6.64e-06	7	202	3	32086392
Pubmed	Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.	HNRNPA1L2 HNRNPA1 HNRNPA2B1 PTGS2	7.44e-06	22	202	4	12456657
Pubmed	Nuclear translocation of hypoxia-inducible factors (HIFs): involvement of the classical importin alpha/beta pathway.	KPNA6 KPNA1 EPAS1	1.06e-05	8	202	3	18187047
Pubmed	Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development.	PDGFRB AKT1 KRIT1 TJP1	1.07e-05	24	202	4	20371769
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	NCKAP1 EIF3E PSMD1 KPNA6 CHD4 PSMD11 PSMD13 GDI1 GDI2 HNRNPA1 PGD HNRNPA2B1 SF3B2 MOV10 KPNA1 SRGAP2 ACTR1A VAC14 GYS1 CTPS1	1.38e-05	1149	202	20	35446349
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	NCKAP1 EIF3E PSMD1 KPNA6 PSMD11 PSMD13 GDI1 GDI2 HNRNPA1 PGD HNRNPA2B1 CHUK PYGB RIPOR1 KPNA1 GPC1 LAMB1 ELP3 ACTR1A LIG1 NAMPT CTPS1 IPO11	1.42e-05	1455	202	23	22863883
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MAST4 SUPT6H PPIP5K2 BSN ARAP1 AKAP6 VPS39 USP28 RHOBTB3 WDR19 LRRC8A RAB11FIP5 DEPDC5	1.50e-05	529	202	13	14621295
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	PSMD1 PSMD13 ZCCHC2 EPB41L3 CNTN1 VPS39 RHOBTB3 NPHP3 RAB11FIP5 CWF19L1	1.64e-05	313	202	10	38270169
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	TPTE CD109 PSMD1 KPNA6 PSMD11 HNRNPA1L2 PSMD13 PGD HNRNPA2B1 WWC2 SSH1 SF3B2 WWC1 KPNA1 LAMB1 NUP214 ELP3 TJP1	1.73e-05	974	202	18	28675297
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	NCKAP1 KPNA6 CHD4 CMAS DNAH5 HSDL1 MOV10 KPNA1 APAF1 ACTR1A LIG1 NAMPT GYS1 CTPS1 CDC23	1.77e-05	704	202	15	29955894
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	EIF3E HNRNPA1L2 MAST2 HNRNPA1 TENM2 HNRNPA2B1 SRGAP1 DLG2 MOV10 VPS39 NUP214 PIGT	1.86e-05	462	202	12	31138677
Pubmed	USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta.	PDGFRB AKT1 USP22 GCM1 EPAS1	1.89e-05	56	202	5	30718289
Pubmed	SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.	EIF3E PSMD1 KPNA6 PSMD11 GDI2 HNRNPA1 PGD HNRNPA2B1 VPS39 NUP214 NAMPT CTPS1	1.90e-05	463	202	12	34901782
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CHD4 LMTK3 SRCAP EPB41L3 CMAS HNRNPA1 HNRNPA2B1 XAB2 ZNF462 SUPT6H PPIP5K2 HSDL1 SF3B2 KRT78 USP22 TJP1 GYS1 AFF4 SPIN3	2.02e-05	1082	202	19	38697112
Pubmed	TERRA transcripts are bound by a complex array of RNA-binding proteins.	HNRNPA1L2 HNRNPA1 HNRNPA2B1 KRT78	2.03e-05	28	202	4	20975687
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	EIF3E PSMD1 HNRNPA1L2 GDI1 GDI2 HNRNPA1 PGD HNRNPA2B1 XAB2 PURA SF3B2 MOV10 ACTR1A CTPS1 SPIN3	2.08e-05	714	202	15	28302793
Pubmed	Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.	KPNA6 AKT1 KPNA1	2.25e-05	10	202	3	19270695
Pubmed	Mammalian Cdh1/Fzr mediates its own degradation.	PSMD1 PSMD11 PSMD13 PSMF1 CDC23	2.44e-05	59	202	5	15029244
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	NCKAP1 EIF3E PSMD1 KPNA6 CHD4 PSMD11 PSMD13 SUPT6H SF3B2 NUP214 ACTR1A NAMPT CTPS1 IPO11	2.46e-05	638	202	14	33239621
Pubmed	Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.	TENT5C PTGS2 STN1 NRP2 SEPTIN1 DLG2 FGFR3 CA6 RAPGEF4 VAC14 CDC23	2.60e-05	402	202	11	24722188
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	EIF3E PSMD1 CHD4 PSMD11 PSMD13 PGD SUPT6H USP27X KPNA1 P4HA2 USP22 USP28 BEND3 NUP214 NMD3 TJP1 GYS1 ABCC12	2.60e-05	1005	202	18	19615732
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	EIF3E PSMD1 PSMD11 PSMD13 HNRNPA1 KRT80 SF3B2 KRT78 RNF213 ACTR1A CCDC87 CTPS1 SPIN3	2.61e-05	558	202	13	27591049
Pubmed	Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice.	HNRNPA1L2 HNRNPA1 HNRNPA2B1 USP28	2.69e-05	30	202	4	28077597
Pubmed	USP14 is a deubiquitinase for Ku70 and critical determinant of non-homologous end joining repair in autophagy and PTEN-deficient cells.	PSMD1 PSMD11 PSMD13 AKT1	2.69e-05	30	202	4	31740976
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	CHD4 HNRNPA1L2 SRCAP HNRNPA2B1 XAB2 SF3B2 RNF213 NUP214 PBRM1 GYS1	2.71e-05	332	202	10	32786267
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DNAH5 MOV10 BEND3 RNF213 FANCM WDR19	2.86e-05	101	202	6	10997877
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYO1G EIF3E PSMD1 KPNA6 PSMD11 GDI1 GDI2 KRT80 CHUK PYGB SF3B2 MOV10 ACTR1A CTPS1	2.86e-05	647	202	14	26618866
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	KPNA6 CHD4 SRCAP EPB41L3 CMAS MAST2 WWC1 KPNA1 USP22 VEZT RHOBTB3 LAMB1 BEND3 RNF213 PBRM1 RAB11FIP5 CLSPN AFF4 CDC23	3.08e-05	1116	202	19	31753913
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	EIF3E PSMD1 XAB2 SUPT6H PURA BSN SF3B2 MOV10 ELP3 NMD3 VAC14 NAMPT GYS1 CWF19L1	3.16e-05	653	202	14	33742100
Pubmed	Systematic identification of factors for provirus silencing in embryonic stem cells.	NCKAP1 EIF3E CHD4 LIG1 VAC14 CTPS1 CDC23	3.33e-05	153	202	7	26365490
Pubmed	WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway.	WWC2 WWC1	3.36e-05	2	202	2	29116649
Pubmed	Post-translational modifications of hnRNP A1 differentially modulate retroviral IRES-mediated translation initiation.	HNRNPA1L2 HNRNPA1	3.36e-05	2	202	2	32960212
Pubmed	The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation.	HGF AKT1	3.36e-05	2	202	2	27224506
Pubmed	Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice.	HNRNPA1 HNRNPA2B1	3.36e-05	2	202	2	22628224
Pubmed	Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation.	HGF AKT1	3.36e-05	2	202	2	20372801
Pubmed	hnRNPA2B1 and hnRNPA1 mutations are rare in patients with "multisystem proteinopathy" and frontotemporal lobar degeneration phenotypes.	HNRNPA1 HNRNPA2B1	3.36e-05	2	202	2	24119545
Pubmed	Antagonistic effects of oxidized low density lipoprotein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma.	AKT1 PPARG	3.36e-05	2	202	2	16407258
Pubmed	Identification of SRGAP2 as a potential oncogene and a prognostic biomarker in hepatocellular carcinoma.	SRGAP1 SRGAP2	3.36e-05	2	202	2	33984363
Pubmed	COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells.	PTGS2 PPARG	3.36e-05	2	202	2	23220503
Pubmed	Silencing of eIF3e promotes blood perfusion recovery after limb ischemia through stabilization of hypoxia-inducible factor 2α activity.	EIF3E EPAS1	3.36e-05	2	202	2	25758454
Pubmed	Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS. The role of Akt, IKKα, and DNA damage repair enzymes.	CHUK AKT1	3.36e-05	2	202	2	25482200
Pubmed	KIBRA promotes prostate cancer cell proliferation and motility.	WWC2 WWC1	3.36e-05	2	202	2	27220053
Pubmed	Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation.	EIF3E EPAS1	3.36e-05	2	202	2	17324924
Pubmed	Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression.	HGF PTGS2	3.36e-05	2	202	2	12393863
Pubmed	Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.	PTGS2 PPARG	3.36e-05	2	202	2	15550453
Pubmed	Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α.	NAMPT EPAS1	3.36e-05	2	202	2	32142369
Pubmed	Cloning of a brain-type isoform of human Rab GDI and its expression in human neuroblastoma cell lines and tumor specimens.	GDI1 GDI2	3.36e-05	2	202	2	7585614
Pubmed	Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein.	PTGS2 PPARG	3.36e-05	2	202	2	11809750
Pubmed	Interplay between hnRNP A1 and a cis-acting element in the 3' UTR of CYP2A5 mRNA is central for high expression of the gene.	HNRNPA1L2 HNRNPA1	3.36e-05	2	202	2	12560094
Pubmed	PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells.	PTGS2 PPARG	3.36e-05	2	202	2	12800228
Pubmed	Telmisartan induces proliferation of human endothelial progenitor cells via PPARgamma-dependent PI3K/Akt pathway.	AKT1 PPARG	3.36e-05	2	202	2	19193378
Pubmed	Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.	PPARG NAMPT	3.36e-05	2	202	2	28408371
Pubmed	FAM46B is a prokaryotic-like cytoplasmic poly(A) polymerase essential in human embryonic stem cells.	TENT5C TENT5B	3.36e-05	2	202	2	32009146
Pubmed	Retroviral insertions downstream of the heterogeneous nuclear ribonucleoprotein A1 gene in erythroleukemia cells: evidence that A1 is not essential for cell growth.	HNRNPA1L2 HNRNPA1	3.36e-05	2	202	2	1406633
Pubmed	NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction.	AKT1 NAMPT	3.36e-05	2	202	2	22251423
Pubmed	USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer.	PTGS2 USP22	3.36e-05	2	202	2	25817787
Pubmed	Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo.	PTGS2 AKT1	3.36e-05	2	202	2	19925030
Pubmed	Heterogeneous nuclear ribonucleoprotein A1 regulates rhythmic synthesis of mouse Nfil3 protein via IRES-mediated translation.	HNRNPA1L2 HNRNPA1	3.36e-05	2	202	2	28220845
Pubmed	Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.	HNRNPA1 HNRNPA2B1	3.36e-05	2	202	2	23455423
Pubmed	Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.	HGF AKT1	3.36e-05	2	202	2	17099727
Pubmed	Prognostic significance of cyclooxygenase 2 and phosphorylated Akt1 overexpression in primary nonmetastatic and metastatic cutaneous melanomas.	PTGS2 AKT1	3.36e-05	2	202	2	28604419
Pubmed	Congenital hydrocephalus in hy3 mice is caused by a frameshift mutation in Hydin, a large novel gene.	VAC14 HYDIN	3.36e-05	2	202	2	12719380
Pubmed	n-3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARgamma activation in human keratinocyte HaCaT cells.	PTGS2 PPARG	3.36e-05	2	202	2	17459764
Pubmed	hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis.	HNRNPA1L2 HNRNPA1	3.36e-05	2	202	2	36382566
Pubmed	Role of PPARγ in COX-2 activation in mycobacterial pulmonary inflammation.	PTGS2 PPARG	3.36e-05	2	202	2	22696146
Pubmed	Plasma Levels of Cyclooxygenase-2 (COX-2) and Visfatin During Different Stages and Different Subtypes of Migraine Headaches.	PTGS2 NAMPT	3.36e-05	2	202	2	28044053
Pubmed	Human lung fibroblasts produce proresolving peroxisome proliferator-activated receptor-γ ligands in a cyclooxygenase-2-dependent manner.	PTGS2 PPARG	3.36e-05	2	202	2	27612965
Pubmed	Loss of hnRNP A1 in murine skeletal muscle exacerbates high-fat diet-induced onset of insulin resistance and hepatic steatosis.	HNRNPA1L2 HNRNPA1	3.36e-05	2	202	2	31169879
Pubmed	Cytoplasmic polyadenylation by TENT5A is required for proper bone formation.	TENT5C TENT5A	3.36e-05	2	202	2	33882302
Pubmed	Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.	PTGS2 PPARG	3.36e-05	2	202	2	27431935
Pubmed	siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference.	HNRNPA1L2 HNRNPA1	3.36e-05	2	202	2	15215364
Pubmed	Phosphorylation of hnRNP A1-Serine 199 Is Not Required for T Cell Differentiation and Function.	HNRNPA1L2 HNRNPA1	3.36e-05	2	202	2	38334757
Pubmed	A Function for the hnRNP A1/A2 Proteins in Transcription Elongation.	HNRNPA1 HNRNPA2B1	3.36e-05	2	202	2	26011126
Pubmed	MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function.	ABCC5 ABCC12	3.36e-05	2	202	2	35121660
Interaction	FCMR interactions	HNRNPA1L2 HNRNPA1 HNRNPA2B1 DNAH6	2.83e-06	11	198	4	int:FCMR
Cytoband	5q31	PURA P4HA2 PCDHGA10 AFF4 CDC23	1.63e-04	115	202	5	5q31
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	FCHSD2 SRGAP2C SRGAP1 SRGAP2 SRGAP2B	1.03e-06	23	148	5	1288
GeneFamily	Dyneins, axonemal	DNAH5 DNAH6 DNAH10	3.36e-04	17	148	3	536
GeneFamily	C2 and WW domain containing	WWC2 WWC1	3.95e-04	4	148	2	838
GeneFamily	Armadillo repeat containing\|Importins	KPNA6 KPNA1 IPO11	4.01e-04	18	148	3	596
GeneFamily	Proteasome	PSMD1 PSMD11 PSMD13 PSMF1	4.15e-04	43	148	4	690
GeneFamily	Tudor domain containing\|Spindlin family	SPIN4 SPIN3	6.55e-04	5	148	2	1089
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TMTC2 TTC9C NPHP3 EMC2 CDC23	2.56e-03	115	148	5	769
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	ALS2CL TENM2 FCHSD2 SRGAP2C SRGAP1 DLG2 DPP6 SRGAP2 TJP1 PRKG1 MBD5	8.02e-07	212	201	11	M39221
Coexpression	GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN	ADAM10 RBSN HSDL1 ARAP1 P4HA2 VEZT ABCC5 ELP3 LIG1 EMC2	3.12e-06	197	201	10	M3123
Coexpression	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN	PDGFRB SPIN4 SYT5 FGFR3 COL6A6 NKD2 GUCY1A2 EPAS1	8.50e-06	132	201	8	M6764
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ATP8B1 ALS2CL TENM2 SRGAP2C DLG2 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	8.25e-10	183	202	11	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ATP8B1 ALS2CL TENM2 SRGAP2C DLG2 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	8.25e-10	183	202	11	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ATP8B1 ALS2CL TENM2 SRGAP2C DLG2 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	8.74e-10	184	202	11	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A PPM1H PKHD1 WWC1 DPP6 LAMB1 DGKI RP1 PRKG1 HYDIN CACNA2D3	1.04e-09	187	202	11	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A EML6 ADAM10 PPM1H ZNF462 PKHD1 DNAH5 WWC1 LAMB1 HYDIN CACNA2D3	1.30e-09	191	202	11	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B PRKG1	1.10e-08	181	202	10	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B PRKG1	1.10e-08	181	202	10	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.23e-08	183	202	10	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.23e-08	183	202	10	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.36e-08	185	202	10	9197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.36e-08	185	202	10	ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.36e-08	185	202	10	b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A PPM1H PKHD1 WWC1 LAMB1 DGKI RP1 PRKG1 HYDIN CACNA2D3	1.43e-08	186	202	10	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A PPM1H PKHD1 WWC1 LAMB1 DGKI RP1 PRKG1 HYDIN CACNA2D3	1.59e-08	188	202	10	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	TENT5C B3GALT5 MAST4 FGFR3 B4GALNT3 HSD17B2 DNAH5 WWC1 ABCC5 CELSR1	1.75e-08	190	202	10	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	TENT5C B3GALT5 MAST4 FGFR3 B4GALNT3 DNAH5 WWC1 ABCC5 CELSR1 RP1	2.04e-08	193	202	10	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.24e-07	177	202	9	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.30e-07	178	202	9	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.36e-07	179	202	9	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TENT5C B3GALT5 FGFR3 DNAH5 WWC1 CNTN1 ABCC5 CELSR1 RP1	1.57e-07	182	202	9	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TENT5C B3GALT5 ATP8B1 B4GALNT3 HSD17B2 DNAH5 FYB2 CELSR1 CHP2	1.57e-07	182	202	9	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.64e-07	183	202	9	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	COVID-19-kidney-Podocyte\|kidney / Disease (COVID-19 only), tissue and cell type	PDGFRB ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.64e-07	183	202	9	fb5e2a31b560126e1c04a386c24c365901c60ad7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	1.64e-07	183	202	9	612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	2.06e-07	188	202	9	9db778c1d9e622a68337212296e3a1ed8f771fa5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ADAM10 PPM1H ZNF462 PKHD1 WWC1 CELSR1 HYDIN CACNA2D3	2.06e-07	188	202	9	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	2.06e-07	188	202	9	047c4e0b03fc8334e38c48977e41d26dbe229d47
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EML6 TMTC2 PKHD1 CRYBG1 B4GALNT3 FYB2 RHOBTB3 LAMB1 PRKG1	2.16e-07	189	202	9	8ff3c3232eff9de4b5c9b22ecb82bc509d773f58
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A EML6 PPM1H ZNF462 PKHD1 DNAH6 WWC1 CELSR1 HYDIN	2.16e-07	189	202	9	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	NCKAP1 MAST4 B4GALNT3 DNAH5 DNAH6 FYB2 WWC1 RP1 HYDIN	2.47e-07	192	202	9	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	COVID-19-kidney-CNT\|kidney / Disease (COVID-19 only), tissue and cell type	TMTC2 PKHD1 CRYBG1 B4GALNT3 FYB2 RHOBTB3 LAMB1 ABCC5 PRKG1	2.47e-07	192	202	9	d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	C6orf118 DNAH5 DNAH6 FYB2 AKAP6 DNAH10 CELSR1 RP1 HYDIN	2.58e-07	193	202	9	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	EML6 TMTC2 ATP8B1 PKHD1 CRYBG1 FYB2 RHOBTB3 LAMB1 PPARG	2.58e-07	193	202	9	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	2.58e-07	193	202	9	3eaa0461618582a1754400624350d269d24e750a
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	C6orf118 MAST4 DNAH5 DNAH6 FYB2 WWC1 DNAH10 RP1 HYDIN	2.81e-07	195	202	9	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A PPM1H MAST4 PKHD1 WWC1 RHOBTB3 LAMB1 RP1 CACNA2D3	2.81e-07	195	202	9	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	NCKAP1 MAST4 DNAH5 DNAH6 FYB2 WWC1 RP1 CLSPN HYDIN	2.94e-07	196	202	9	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	NCKAP1 MAST4 DNAH5 DNAH6 FYB2 WWC1 RP1 CLSPN HYDIN	2.94e-07	196	202	9	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	C6orf118 DNAH5 DNAH6 FYB2 WWC1 DNAH10 CELSR1 RP1 HYDIN	2.94e-07	196	202	9	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	KRT80 HSD17B2 DNAH5 DNAH6 FYB2 KRT78 DNAH10 CELSR1 HYDIN	3.20e-07	198	202	9	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	KRT80 HSD17B2 DNAH5 DNAH6 FYB2 KRT78 DNAH10 CELSR1 HYDIN	3.20e-07	198	202	9	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PGD PTGS2 PPM1H MAST4 CALB2 TENT5A RHOBTB3 NAMPT VWA5A	3.34e-07	199	202	9	a24a319d3ba8f4759f742af27610b4d62e359a2d
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	KRT80 C6orf118 HSD17B2 DNAH5 DNAH6 KRT78 DNAH10 RP1 HYDIN	3.48e-07	200	202	9	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EML6 C6orf118 B4GALNT3 DNAH5 DNAH6 FYB2 DNAH10 RP1 HYDIN	3.48e-07	200	202	9	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	KRT80 C6orf118 HSD17B2 DNAH5 DNAH6 KRT78 DNAH10 RP1 HYDIN	3.48e-07	200	202	9	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Basal_2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	GJB4 LMTK3 MAST4 FGFR3 GPC1 TJP1 CHP2 LRRC8A EPAS1	3.48e-07	200	202	9	0fa3340d945f00ef55c7603476d51bd8346e82c2
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TENT5C LMTK3 C6orf118 TONSL SEPTIN1 B4GALNT4 CELSR1 TIGIT	1.03e-06	168	202	8	6c758eb120faf06ff72d157b495e399191c79ec9
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKHD1 DNAH5 DNAH6 DNAH10 PKHD1L1 DGKI RP1 HYDIN	1.08e-06	169	202	8	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2 SRGAP2B	1.23e-06	172	202	8	6c17a1e586a72d1bd80c20c06370429c61dc9f85
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 SRGAP2 SRGAP2B	1.23e-06	172	202	8	381ae1c3c07d0a424f43455ec571653b192a946a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2 SRGAP2B	1.35e-06	174	202	8	dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ALS2CL TENM2 SRGAP2C RIPOR1 CNTN1 DPP6 SRGAP2 SRGAP2B	1.40e-06	175	202	8	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO9A EPB41L3 WWC2 PKHD1 WWC1 DPP6 CELSR1 CACNA2D3	1.81e-06	181	202	8	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPB41L3 PKHD1 WWC1 DPP6 TENT5A TENT5B CELSR1 CACNA2D3	1.88e-06	182	202	8	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 TJP1 SRGAP2B	1.88e-06	182	202	8	cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	TENT5C B3GALT5 ATP8B1 B4GALNT3 HSD17B2 FYB2 CELSR1 CHP2	1.96e-06	183	202	8	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A EML6 ADAM10 PPM1H PKHD1 WWC1 CELSR1 HYDIN	2.04e-06	184	202	8	da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPB41L3 ALS2CL WWC2 FYB2 RHOBTB3 TJP1 RP1 CACNA2D3	2.13e-06	185	202	8	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO9A EPB41L3 WWC2 PKHD1 WWC1 DPP6 CELSR1 CACNA2D3	2.21e-06	186	202	8	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2 TJP1 SRGAP2B	2.30e-06	187	202	8	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	ATP8B1 PPM1H FCHSD2 RASGRF2 RAPGEF4 PKHD1L1 DGKI EPAS1	2.49e-06	189	202	8	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A EML6 TMTC2 PKHD1 LAMB1 RP1 MBD5 CACNA2D3	2.49e-06	189	202	8	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TMTC2 PKHD1 CRYBG1 B4GALNT3 FYB2 RHOBTB3 LAMB1 PRKG1	2.59e-06	190	202	8	4836ea19308d2a96694f12ab0653b7ce7b101d2f
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HDAC9 EPB41L3 FCHSD2 SRGAP1 AKAP6 ABCC5 SRGAP2 SRGAP2B	2.59e-06	190	202	8	f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TENT5C MAST4 FGFR3 DNAH5 WWC1 ABCC5 CELSR1 RP1	2.70e-06	191	202	8	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C SRGAP1 RIPOR1 DPP6 TJP1 SRGAP2B	2.80e-06	192	202	8	ef0aba777072429a6ab7dcfcc305673975946580
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDGFRB EIF3E HNRNPA1 HSD17B2 CNTN1 CALB2 LAMB1 PRKG1	2.91e-06	193	202	8	68089ba4123e2f9bea9aae0023a844b5a57bfc0e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	HGF PDGFRB TENM2 SRGAP1 COL6A6 LAMB1 NKD2 PRKG1	2.91e-06	193	202	8	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HGF PDGFRB SRGAP1 DLG2 COL6A6 LAMB1 GUCY1A2 PRKG1	2.91e-06	193	202	8	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A PPM1H PKHD1 DNAH5 WWC1 RNF213 HYDIN CACNA2D3	3.03e-06	194	202	8	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	MAST4 DNAH5 DNAH6 FYB2 WWC1 DNAH10 RP1 HYDIN	3.15e-06	195	202	8	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	MAST4 DNAH5 DNAH6 FYB2 WWC1 DNAH10 RP1 HYDIN	3.15e-06	195	202	8	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TENT5C MAST4 FGFR3 B4GALNT3 WWC1 ABCC5 CELSR1 RP1	3.15e-06	195	202	8	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO9A TMTC2 WWC2 MAST4 DLG2 DNAH5 WWC1 PRKG1	3.15e-06	195	202	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	(5)_Fibroblast-I\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	HGF TENM2 SRGAP1 GPC1 P4HA2 NKD2 KANK4 PRKG1	3.39e-06	197	202	8	eb486995ad72a0fbb6410c54e8dcf4ee780c0986
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	C6orf118 DNAH5 DNAH6 FYB2 AKAP6 DNAH10 RP1 HYDIN	3.39e-06	197	202	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	PDGFRB SRGAP1 COL6A6 LAMB1 NKD2 GUCY1A2 GREB1 PRKG1	3.52e-06	198	202	8	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	HGF PDGFRB SRGAP1 DLG2 COL6A6 LAMB1 NKD2 PRKG1	3.52e-06	198	202	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	C6orf118 SYT5 B4GALNT3 DNAH5 DNAH6 DNAH10 RP1 HYDIN	3.65e-06	199	202	8	15f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCell	LPS_anti-TNF-Epithelial_airway\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	KRT80 HSD17B2 DNAH5 KRT78 DNAH10 TM4SF5 CELSR1 HYDIN	3.65e-06	199	202	8	6aca164bbbb961f34b1e6f1857f91ade5c059405
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	KRT80 HSD17B2 DNAH5 KRT78 DNAH10 TM4SF5 CELSR1 HYDIN	3.65e-06	199	202	8	60919c2af31d39a2d36d7bc432e43dab2a4e05fb
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KRT80 C6orf118 SYT5 HSD17B2 DNAH5 KRT78 DNAH10 HYDIN	3.79e-06	200	202	8	cf191104484bfb2b9f87de416b9453135f8833c1
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO9A EPB41L3 WWC2 PKHD1 WWC1 DPP6 CELSR1 CACNA2D3	3.79e-06	200	202	8	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	LPS_IL1RA-Epithelial_airway\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KRT80 C6orf118 SYT5 HSD17B2 DNAH5 KRT78 DNAH10 HYDIN	3.79e-06	200	202	8	a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO9A WWC2 PKHD1 WWC1 DPP6 CELSR1 CATSPER4 CACNA2D3	3.79e-06	200	202	8	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO9A EPB41L3 WWC2 PKHD1 WWC1 DPP6 CATSPER4 CACNA2D3	3.79e-06	200	202	8	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	C6orf118 SYT5 DNAH5 DNAH6 FYB2 DNAH10 RP1 HYDIN	3.79e-06	200	202	8	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EML6 SYT5 DNAH5 DNAH6 DNAH10 RP1 HYDIN	6.74e-06	154	202	7	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EML6 SYT5 DNAH5 DNAH6 DNAH10 RP1 HYDIN	6.74e-06	154	202	7	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	B3GALT5 ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2	7.03e-06	155	202	7	90e629681a72baacc7981b82883866a487638dbc
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	B3GALT5 ATP8B1 B4GALNT3 HSD17B2 FYB2 CELSR1 CHP2	9.01e-06	161	202	7	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	LPS-IL1RA-Epithelial_airway\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	B3GALT5 KRT80 HSD17B2 DNAH5 KRT78 CELSR1 CHP2	9.01e-06	161	202	7	472c354f5ee148b37a5dfb795e83348ecb1643f1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB PTGS2 SNX15 CNTN1 NKD2 GUCY1A2 PRKG1	9.38e-06	162	202	7	68c40d12689cc1b6c797e6e48173f0110f8144e4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB PTGS2 SNX15 CNTN1 NKD2 GUCY1A2 PRKG1	9.38e-06	162	202	7	735fa3f77b31a4189e431d05c326403c18cbbffb
ToppCell	Club_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	GJB4 TENT5C B3GALT5 BSN B4GALNT4 APOB CELSR1	1.02e-05	164	202	7	4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5
ToppCell	Club_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	TENT5C B3GALT5 HSD17B2 FYB2 RHOBTB3 SERPINA11 CHP2	1.10e-05	166	202	7	a440aa338aa0c6cd0b5800dfa7e83f8ca16fce1a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2 TJP1	1.19e-05	168	202	7	fc80e4fecfc92458eb627013a983041d8ca025a9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ALS2CL TENM2 SRGAP2C RIPOR1 DPP6 SRGAP2 TJP1	1.19e-05	168	202	7	315ca578c945aeeb77acda2727f3e6db8b43f43e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1 DNAH5 WWC1 LAMB1 CELSR1 RP1 CACNA2D3	1.38e-05	172	202	7	eeed177a03c116e9815a8e086d24efc9643b16a4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PKHD1 DNAH5 WWC1 LAMB1 CELSR1 RP1 CACNA2D3	1.38e-05	172	202	7	0c2d0bb767e5ce089b42ad49e8b303a103de2d5c
Drug	DMOG	AKT1 P4HA2 PPARG NAMPT EPAS1	2.18e-06	25	198	5	CID000560326
Disease	white matter microstructure measurement	HGF PSMD1 MAST2 HNRNPA1L3 TENM2 STN1 MAST4 PSMF1 GAL3ST1 ABCC5 APOB SRGAP2 CACNA2D3	2.94e-06	390	200	13	EFO_0005674
Disease	focal segmental glomerulosclerosis (implicated_via_orthology)	MYO9A CMAS SRGAP1	1.05e-05	7	200	3	DOID:1312 (implicated_via_orthology)
Disease	cortical thickness	HDAC9 AS3MT CMAS MAST2 ADAM10 HNRNPA1L3 TENM2 STN1 NRP2 ZNF462 MAST4 PKHD1 PYGB FGFR3 AKAP6 P4HA2 BEND3 SRGAP2 CELSR1 DGKI CACNA2D3	2.44e-05	1113	200	21	EFO_0004840
Disease	pancreatic cancer (is_marker_for)	HGF B3GALT5 PTGS2 AKT1 APAF1 ABCC5	6.68e-05	101	200	6	DOID:1793 (is_marker_for)
Disease	brain measurement, neuroimaging measurement	HDAC9 HNRNPA1L3 ZNF462 MAST4 PYGB DLG2 FGFR3 P4HA2 GAL3ST1 BEND3 PBRM1 DGKI EMC2	1.06e-04	550	200	13	EFO_0004346, EFO_0004464
Disease	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	HNRNPA1 HNRNPA2B1	1.37e-04	3	200	2	cv:C1833662
Disease	meningioma (is_marker_for)	HGF EPB41L3	1.37e-04	3	200	2	DOID:3565 (is_marker_for)
Disease	intermittent claudication (implicated_via_orthology)	EIF3E EPAS1	1.37e-04	3	200	2	DOID:3669 (implicated_via_orthology)
Disease	INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	HNRNPA1 HNRNPA2B1	1.37e-04	3	200	2	C1833662
Disease	Barrett Epithelium	HGF PTGS2 PPARG	1.61e-04	16	200	3	C1258085
Disease	Barrett Esophagus	HGF PTGS2 PPARG	1.61e-04	16	200	3	C0004763
Disease	angina pectoris	HDAC9 AS3MT PSMD13 TENT5A RNF213 APOB	2.16e-04	125	200	6	EFO_0003913
Disease	CCL2 measurement	HDAC9 PDGFRB ALS2CL DLG2 GREB1 CACNA2D3	2.26e-04	126	200	6	EFO_0004749
Disease	Astigmatism	MYO1G EML6 EIF3E TENM2 DNAH5 PSMF1	2.56e-04	129	200	6	HP_0000483
Disease	myopathy (implicated_via_orthology)	HNRNPA1L2 HNRNPA1L3 HNRNPA1 HNRNPA2B1	3.16e-04	48	200	4	DOID:423 (implicated_via_orthology)
Disease	Colorectal Carcinoma	CD109 PTGS2 PKHD1 AKT1 FGFR3 CNTN1 AKAP6 RASGRF2 ABCC5 APOB PPARG LIG1 NAMPT GUCY1A2	3.33e-04	702	200	14	C0009402
Disease	cardiovascular system disease (is_implicated_in)	PTGS2 PPARG GYS1	3.73e-04	21	200	3	DOID:1287 (is_implicated_in)
Disease	Malignant neoplasm of breast	TPTE CD109 ATP8B1 EPB41L3 ALS2CL ADAM10 PTGS2 AKT1 AKAP6 GPC1 RASGRF2 VPS39 NUP214 ELP3 PBRM1 GUCY1A2 FCRL5 CLSPN	4.02e-04	1074	200	18	C0006142
Disease	stroke	HDAC9 EPB41L3 STN1 CRYBG1 MARS2 PRKG1	4.62e-04	144	200	6	EFO_0000712
Disease	cancer (implicated_via_orthology)	GDI1 GDI2 DLG2 AKT1 LIG1 KANK4 DEPDC5 EPAS1	5.13e-04	268	200	8	DOID:162 (implicated_via_orthology)
Disease	coronary artery disease	HDAC9 CD109 AS3MT ALS2CL STN1 MAST4 MICB PKHD1 BSN DPP6 P4HA2 TTC41P DNAH10 TENT5A RNF213 APOB GUCY1A2 RP1 PRKG1	5.22e-04	1194	200	19	EFO_0001645
Disease	Colorectal Neoplasms	CD109 PTGS2 AKT1 FGFR3 ABCC5 PPARG NAMPT GUCY1A2	6.37e-04	277	200	8	C0009404
Disease	Amyotrophic Lateral Sclerosis	HNRNPA1 HNRNPA2B1 PTGS2 DPP6	6.53e-04	58	200	4	C0002736
Disease	neuroimaging measurement, brain volume measurement	MAST4 PYGB DLG2 GAL3ST1 BEND3 ACTR1A PBRM1 EMC2	7.84e-04	286	200	8	EFO_0004346, EFO_0006930
Disease	acute kidney failure (implicated_via_orthology)	PTGS2 PPARG EPAS1	7.96e-04	27	200	3	DOID:3021 (implicated_via_orthology)
Disease	Ciliopathies	PKHD1 DNAH5 RDH12 WDR19 NPHP3	9.36e-04	110	200	5	C4277690
Disease	Stage IV Skin Melanoma	ADAM7 ADAM10	9.39e-04	7	200	2	C1321872
Disease	Dengue Hemorrhagic Fever	MICB RP1	9.39e-04	7	200	2	EFO_0004227
Disease	Thyroid cancer, follicular	SRGAP1 PPARG	9.39e-04	7	200	2	C2931367
Disease	biliary tract benign neoplasm (is_marker_for)	HGF CTPS1	9.39e-04	7	200	2	DOID:0050625 (is_marker_for)
Disease	insomnia measurement	HDAC9 HNRNPA1L3 MICB DLG2 PPIP5K2 RASGRF2 ACTR1A PBRM1 DGKI CACNA2D3	9.42e-04	443	200	10	EFO_0007876
Disease	neuroimaging measurement	HDAC9 PSMD1 HNRNPA1L3 NRP2 ZNF462 MAST4 PKHD1 PYGB DLG2 FGFR3 WWC1 GAL3ST1 BEND3 ACTR1A CELSR1 DGKI IPO11	1.04e-03	1069	200	17	EFO_0004346
Disease	response to angiotensin receptor blocker	EML6 AS3MT TENM2	1.09e-03	30	200	3	EFO_0010735
Disease	platelet measurement	HDAC9 EML6 C6orf118 MICB SYT5 MOV10 P4HA2 PBRM1	1.45e-03	315	200	8	EFO_0005036
Disease	serum gamma-glutamyl transferase measurement	MYO9A AKR1C4 ATP8B1 HNRNPA1L3 TENM2 WWC2 SSH1 PKHD1 KRT78 TM4SF5 PPARG PBRM1 TJP1 RP1 MAST3	1.50e-03	914	200	15	EFO_0004532
Disease	Vasodilators used in cardiac diseases use measurement	HDAC9 RNF213 APOB	1.57e-03	34	200	3	EFO_0009926
Disease	Autosomal Recessive Polycystic Kidney Disease	PKHD1 NPHP3	1.59e-03	9	200	2	C0085548
Disease	glioblastoma (implicated_via_orthology)	USP27X USP22	1.59e-03	9	200	2	DOID:3068 (implicated_via_orthology)
Disease	cognitive function measurement	ATP8B1 ZCCHC2 HNRNPA1L3 C6orf118 MAST4 SRGAP1 PKHD1 CRYBG1 RNF216 DNAH5 ARAP1 AKAP6 ABCC5 PPARG NMD3 WDR19 VAC14 RAB11FIP5 HYDIN CACNA2D3	1.85e-03	1434	200	20	EFO_0008354
Disease	Tinnitus	PKHD1 DLG2 KRT78 APAF1 CACNA2D3	1.96e-03	130	200	5	HP_0000360
Disease	platelet crit	HDAC9 TENT5C STN1 C6orf118 MAST4 MICB SYT5 MOV10 ABCC5 APOB PPARG ACTR1A RP1 CTPS1 SPIN3	2.22e-03	952	200	15	EFO_0007985
Disease	skin microbiome measurement	SRGAP2 PPARG GUCY1A2	2.34e-03	39	200	3	EFO_0801228
Disease	insulin measurement	HDAC9 MICB DLG2 ARAP1 DNAH10 PPARG PRKG1	2.39e-03	267	200	7	EFO_0004467
Disease	complement C1q tumor necrosis factor-related protein 5 measurement	P4HA2 APAF1	2.42e-03	11	200	2	EFO_0801494
Disease	cerebral cavernous malformation (implicated_via_orthology)	RNF213 KRIT1	2.42e-03	11	200	2	DOID:0060669 (implicated_via_orthology)
Disease	histidine betaine (hercynine) measurement	P4HA2 UGT1A4	2.42e-03	11	200	2	EFO_0800972
Disease	Moyamoya disease	HDAC9 RAPGEF4 RNF213	2.52e-03	40	200	3	MONDO_0016820
Disease	chronic obstructive pulmonary disease	HDAC9 EIF3E STN1 NRP2 DLG2 FGFR3 DNAH5 AKAP6 RHOBTB3 SRGAP2 BTN2A1 CACNA2D3	2.70e-03	688	200	12	EFO_0000341
Disease	Carcinoma, Transitional Cell	PTGS2 FGFR3 APAF1	2.71e-03	41	200	3	C0007138
Disease	red blood cell density measurement	MYO9A TENT5C CHD4 ATP8B1 MAST2 STN1 ZNF462 WWC2 C6orf118 PKHD1 DNAH10 PPARG VAC14 PBRM1	2.84e-03	880	200	14	EFO_0007978
Disease	ficolin-3 measurement	B4GALNT3 RP1	2.89e-03	12	200	2	EFO_0020392
Disease	Renal dysplasia and retinal aplasia (disorder)	WDR19 NPHP3	2.89e-03	12	200	2	C0403553
Disease	neurodegenerative disease (implicated_via_orthology)	HNRNPA1L2 HNRNPA1L3 HNRNPA1 HNRNPA2B1 MARS2	3.15e-03	145	200	5	DOID:1289 (implicated_via_orthology)
Disease	Osteogenesis Imperfecta	TAPT1 TENT5A	3.39e-03	13	200	2	C0029434
Disease	Skin Abnormalities	CHUK APAF1	3.39e-03	13	200	2	C0037268
Disease	Nephronophthisis	WDR19 NPHP3	3.39e-03	13	200	2	C0687120
Disease	non-high density lipoprotein cholesterol measurement	ATP8B1 SSH1 PYGB B4GALNT3 DNAH10 APOB PPARG UGT1A4 PBRM1 RP1 CWF19L1 HYDIN	3.59e-03	713	200	12	EFO_0005689
Disease	age at onset, Myopia	IGLV11-55 DLG2 AKAP6 DPP6 HYDIN	3.64e-03	150	200	5	EFO_0004847, HP_0000545
Disease	QT interval	MAST2 C6orf118 DPP6 RASGRF2 BEND3 NKD2 MBD5 EPAS1 CDC23 IPO11	3.67e-03	534	200	10	EFO_0004682
Disease	Neurodevelopmental Disorders	NCKAP1 SRCAP PURA CACNA2D3	3.74e-03	93	200	4	C1535926
Disease	social interaction measurement	TENM2 DPP6 KANK4 MBD5	3.88e-03	94	200	4	EFO_0009592
Disease	hematocrit	MYO9A AS3MT AKR1C4 ATP8B1 MAST2 PGD ZNF462 PKHD1 BSN APOB PPARG VAC14 HYDIN EPAS1 SPIN3	3.90e-03	1011	200	15	EFO_0004348
Disease	renal cell carcinoma (biomarker_via_orthology)	PTGS2 EPAS1	3.94e-03	14	200	2	DOID:4450 (biomarker_via_orthology)
Disease	polycystic kidney disease (implicated_via_orthology)	PTGS2 PPARG	3.94e-03	14	200	2	DOID:0080322 (implicated_via_orthology)
Disease	mean platelet volume	HDAC9 EML6 TENT5C PSMD13 SRCAP HNRNPA1 MAST4 SSH1 RIPOR1 ARAP1 COL6A6 PCDHGA10 ABCC5 LRRC8A SPIN3	4.22e-03	1020	200	15	EFO_0004584
Disease	colorectal cancer (is_marker_for)	CHD4 ADAM10 AKT1 PBRM1 AFF4	4.42e-03	157	200	5	DOID:9256 (is_marker_for)
Disease	developmental disorder of mental health (implicated_via_orthology)	NCKAP1 SRCAP DLG2	4.49e-03	49	200	3	DOID:0060037 (implicated_via_orthology)
Disease	triacylglycerol 52:3 measurement	FGFR3 APOB	4.53e-03	15	200	2	EFO_0010415
Disease	cortical surface area measurement	HDAC9 HGF MAST2 HNRNPA1L3 TENM2 STN1 MAST4 PKHD1 FGFR3 WWC1 MOV10 BEND3 ACTR1A CELSR1 TJP1 RMDN1 DGKI PRKG1	4.78e-03	1345	200	18	EFO_0010736
Disease	free cholesterol to total lipids in small HDL percentage	ADAM10 APOB PPARG	5.03e-03	51	200	3	EFO_0022285
Disease	myopia (is_implicated_in)	HGF P4HA2	5.15e-03	16	200	2	DOID:11830 (is_implicated_in)
Disease	colorectal mucinous adenocarcinoma	TRPM1 RASGRF2	5.15e-03	16	200	2	EFO_0009361
Disease	T-Cell Lymphoma	AKT1 PPARG	5.15e-03	16	200	2	C0079772
Disease	gliosarcoma	FGFR3 PPARG	5.15e-03	16	200	2	C0206726
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	PKHD1 AKT1	5.15e-03	16	200	2	DOID:0110861 (implicated_via_orthology)
Disease	Polyposis, Adenomatous Intestinal	PTGS2 AKT1	5.15e-03	16	200	2	C2713442
Disease	Familial Intestinal Polyposis	PTGS2 AKT1	5.15e-03	16	200	2	C2713443
Disease	body mass index, type 2 diabetes mellitus	ARAP1 PPARG	5.15e-03	16	200	2	EFO_0004340, MONDO_0005148
Disease	brain ischemia (biomarker_via_orthology)	PTGS2 AKT1 APAF1 TJP1	5.19e-03	102	200	4	DOID:2316 (biomarker_via_orthology)
Disease	Squamous cell carcinoma of the head and neck	PTGS2 AKT1 NAMPT	5.31e-03	52	200	3	C1168401
Disease	ceramide measurement	HDAC9 ATP8B1 GAL3ST1 APOB NMD3 CHP2	5.49e-03	235	200	6	EFO_0010222
Disease	reaction time measurement	MYO1G HNRNPA1L3 TENM2 PKHD1 CNTN1 AKAP6 GPC1 DNAH10 SRGAP2 DGKI EPAS1	5.49e-03	658	200	11	EFO_0008393
Disease	interleukin 1 receptor antagonist measurement	AKAP6 LILRA2 KANK4	5.60e-03	53	200	3	EFO_0004754
Disease	serum selenium measurement	PKHD1 USP22 PRKG1	5.60e-03	53	200	3	EFO_0005266
Disease	body fat percentage, type 2 diabetes mellitus	ARAP1 PPARG	5.81e-03	17	200	2	EFO_0007800, MONDO_0005148
Disease	Multiple congenital anomalies	CHUK AFF4	5.81e-03	17	200	2	C0000772
Disease	esophageal carcinoma, gastric carcinoma	MAST2 TRPM1	5.81e-03	17	200	2	EFO_0000178, EFO_0002916
Disease	low density lipoprotein cholesterol measurement, body fat percentage	DNAH10 UGT1A4	5.81e-03	17	200	2	EFO_0004611, EFO_0007800
Disease	Adenomatous Polyposis Coli	PTGS2 AKT1	5.81e-03	17	200	2	C0032580
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	AKR1C4 ADAM10 DNAH10 APOB PPARG PIGT KANK4	5.88e-03	315	200	7	EFO_0004612, EFO_0008591
Disease	lung non-small cell carcinoma (is_marker_for)	HNRNPA1 HNRNPA2B1 PTGS2 AKT1 APAF1	6.01e-03	169	200	5	DOID:3908 (is_marker_for)
Disease	high density lipoprotein particle size measurement	ADAM10 DNAH10 APOB PPARG PIGT	6.16e-03	170	200	5	EFO_0008592
Disease	brain connectivity measurement	HGF MAST2 CLHC1 SSH1 MOV10 P4HA2 ACTR1A LRRC8A	6.17e-03	400	200	8	EFO_0005210

Protein segments in the cluster

Peptide	Gene	Start	Entry
RFYGAEIVSALDYLH	AKT1	251	P31749
AIEAGFRHIDSAYLY	AKR1C4	41	P17516
YLLLHEREDSFYSQG	ALS2CL	776	Q60I27
CDRNGKSFRYYLHDL	APAF1	426	O14727
ELLGRSAYEFYHALD	EPAS1	271	Q99814
KHQARELDGFGLYLY	CDC23	161	Q9UJX2
YLDQKHYELFSTIDD	CATSPER4	116	Q7RTX7
HRYYFEVLHKQNEEG	B4GALNT3	241	Q6L9W6
IQTDHLFFKYYGTRE	ADAM10	226	O14672
YESNRESLLNHFLYE	AFM	151	P43652
KYSDEGEHLVFKYNL	ADAM7	146	Q9H2U9
QRDYFGAHTYELLAK	PGD	446	P52209
HGDIIQKDFLDVYYN	B3GALT5	116	Q9Y2C3
YNGRFNEKHDFIALE	CELSR1	1481	Q9NYQ6
DYFKYLTNHETDFLH	CCDC87	596	Q9NVE4
QEYTLGSEFQFYLHK	CA6	281	P23280
ADGKLAFYDHYLIEQ	ATP8B1	501	O43520
AFYDHYLIEQIQSGK	ATP8B1	506	O43520
LVFDDRNYSADHYLQ	AFF4	906	Q9UHB7
TEEHHLRDYFEQYGK	HNRNPA1L2	116	Q32P51
TEEHHLRDYFEQYGK	HNRNPA1L3	71	A0A2R8Y4L2
GADRHSFLKALYYQD	RBM41	161	Q96IZ5
KDLQSFYQLHSHYEE	RBSN	21	Q9H1K0
LDQSAKYYHLTHDEL	RAB11FIP5	591	Q9BXF6
GSLQAEEYHLYRENK	LILRA2	51	Q8N149
GIKYDLDRHQYNYVD	LRRC8A	96	Q8IWT6
ELFDHRKLGEQYSCY	BEND3	421	Q5T5X7
LHENEGFEYADVLYL	ANKAR	1121	Q7Z5J8
GFEYADVLYLLHSTE	ANKAR	1126	Q7Z5J8
LGHYYADLGQLEREF	AOC2	261	O75106
HDLQSEKRYSRGFAY	RDH12	186	Q96NR8
SIRQDHKGRFYEDFY	DEPDC5	241	O75140
SEYNHLDSDFLKKLY	GDAP2	396	Q9NXN4
YQKAFDLIEHYFGVE	KPNA6	491	O60684
HELYNTIRDYKDEQG	PBRM1	51	Q86U86
GHALALYRTDDYLDQ	GDI2	186	P50395
DLIEHYGKLAFNLDY	GPN2	181	Q9H9Y4
DLYHENKKYFGLSEF	GREB1	846	Q4ZG55
RDFDGKVYYIDHTNR	WWC1	16	Q8IX03
YYRGANLHLEETLAE	GPC1	151	P35052
VHYVSGLKEDYSRLF	CHUK	431	O15111
AFAYLHSKGIIYRDL	PRKG1	471	Q13976
HIDSLFGLDVYDQVY	LIPJ	341	Q5W064
DRKLFYDLASGIYNF	IPO11	166	Q9UI26
LVIDEAHKALGNYAY	FANCM	211	Q8IYD8
QDSAIFDLGHLYEEY	KRT80	121	Q6KB66
RIGDYGLAHSNYKED	LMTK3	281	Q96Q04
HAYKREEGYILDDSH	BSN	3551	Q9UPA5
YFYVELDTGEKLFHR	CWF19L1	466	Q69YN2
QEDSLRTLYRFYHEG	FCRL5	311	Q96RD9
RLFLYHYSDSDKQLG	IGLV11-55	66	A0A075B6I3
LFSQDHLVIYKGYVD	NUDT9	256	Q9BW91
GVLYALRSFDYEQFH	PCDHGA10	516	Q9Y5H3
VSFDGFRADYLKNYE	ENPP4	31	Q9Y6X5
NYSVEDLLYIRDHFD	FAM151B	236	Q6UXP7
AKDGFSARYYLVHQE	NRP2	256	O60462
EYLYFLKHLNEEELG	KRT78	241	Q8N1N4
NERNRDSGYLHLLYK	NUP214	786	P35658
IEDYVQHLSGYHFKL	PTGS2	331	P35354
TLDHYLYEAEEANLG	LAMB1	551	P07942
LFDEARYNLLKGFYT	KRIT1	531	O00522
IRDDYANLHSKEYSE	GGPS1	186	O95749
RHFYYDGELFLSQNL	MICB	131	Q29980
EFGHEFDLYENKDYI	HGF	111	P14210
IGNHASYYKDALRFL	PSMD13	166	Q9UNM6
HYLDLAGIENYTSRF	NKD2	246	Q969F2
EERKAIIGLYNYAHE	NCKAP1	151	Q9Y2A7
DYLSYAVFQLGDLHR	P4HA2	211	O15460
DGRLFKYLLDYLHGE	KCTD18	61	Q6PI47
AYNKGQEFLHRYQEL	ABCC5	1066	O15440
AHYLRNLLFFDLGYD	GAL3ST1	211	Q99999
FDQYIKDSYDLHDLK	APOB	2181	P04114
EYDHGKLNLYLDSVN	CD109	1341	Q6YHK3
IELSRGYNYDSFHED	DNAH6	2471	Q9C0G6
YSFDTKDIHYGLQLF	HYDIN	1386	Q4G0P3
CAFHLGDYKRALEEY	TTC26	66	A0AVF1
AHLKHEFDADLQYEY	CACNA2D3	116	Q8IZS8
ISLQDYEGFHYDKEK	DGKI	731	O75912
YHKGELRLYDVTFEN	CNTN1	371	Q12860
GNLYEEKVHVDFNSY	GCM1	361	Q9NP62
VDAGFLYIFHRLYKD	GJB4	141	Q9NTQ9
ILYNEFNHYDTAVGK	C1QTNF9B	226	B2RNN3
DHREDVYLYISGHLN	C6orf118	51	Q5T5N4
LYLRKEGYDFHSSSE	ACTR1A	196	P61163
AYRVLKHGGELYFSD	AS3MT	171	Q9HBK9
YLADKHGFRQEYLDT	EIF3E	116	P60228
YFQEGRSYDEAILHL	BTN2A1	126	Q7KYR7
YRDYFIRNLHDALSG	ELP3	181	Q9H9T3
QYATLGDYFRALHAL	MAN2B2	321	Q9Y2E5
FAETVLALEYLHNYG	MAST2	616	Q6P0Q8
FAETVLALEYLHNYG	MAST3	471	O60307
EEFYYLLEAAEGHAK	MAST4	491	O15021
ENSLVKDYIHYNGDF	MBD5	1326	Q9P267
YGFHLDLDFLKYVDD	KANK4	31	Q5T7N3
FYDKDRSGYIDEHEL	CALB2	206	P22676
KRDYEVDGRDYHFVI	DLG2	716	Q15700
GHALALYRTDDYLDQ	GDI1	186	P31150
KYLAVASHDNFVDIY	EML6	1096	Q6ZMW3
LAELYINEHDYAKAA	EMC2	161	Q15006
LTRDKYDEGLYRFNS	DCLRE1A	366	Q6PJP8
DHFSRALQYEYASKG	HSDL1	226	Q3SXM5
FTGHQYLLEEGEYRD	CRYBG1	1281	Q9Y4K1
ALDGNVYDHLKDYLI	FCHSD2	236	O94868
SILYISLHRYDEGNF	HDAC9	836	Q9UKV0
FGLARDVHNLDYYKK	FGFR3	636	P22607
KLYASAFSERYLGLH	DPP6	746	P42658
HFYGHLDFNLDKTLY	GYS1	311	P13807
LLEDFLEHEGYKYER	CHD4	1081	Q14839
EYKYDGQRAQIHALE	LIG1	566	P18858
IGIYDYFAKRHFGQD	HSD17B2	356	P37059
LAREQLSKQYHYDFG	DNAH10	1991	Q8IVF4
LGDKEVDYDSNFRLY	DNAH10	3511	Q8IVF4
EHLNLLEKDYFGLTY	EPB41L3	141	Q9Y2J2
LEKDYFGLTYRDAEN	EPB41L3	146	Q9Y2J2
YYVHDFDALKDIRNQ	COL6A6	591	A6NMZ7
KYAARGLYEEHKFLF	DNAH5	3881	Q8TE73
YIDAEHLGDFHRTYK	PSMF1	111	Q92530
YGDLVDYLHRNKHTF	PDGFRB	686	P09619
TYLELHSLDDFYIGK	RHOBTB3	171	O94955
AYRKESDIENFLGFY	RP1	1936	P56715
YEHQVIGYRDAEKNF	GUCY1A2	116	P33402
KHELGRLQYSLDYDF	SYT5	106	O00445
NYRHAYDLIQKFGDL	VAC14	641	Q08AM6
QDKYLFYRFLDDEHE	RAPGEF4	281	Q8WZA2
SLADYYIRSGHFEKA	XAB2	261	Q9HCS7
YIRSGHFEKARDVYE	XAB2	266	Q9HCS7
GFDNLYYVTREDKDL	STN1	286	Q9H668
NASVFKYYIHDLSDL	SRGAP1	251	Q7Z6B7
NGLYHYAVFEETLEK	TMEM126B	211	Q8IUX1
YRSSFYALEEKHVGF	NBPF12	1321	Q5TAG4
LLAKIFYDRAEYLHG	MOV10	106	Q9HCE1
LYENGSFYFAKRHLI	CMAS	211	Q8NFW8
AHELGFEKYYQRLND	NPHP3	501	Q7Z494
DALDKQYYFTVLFGH	RASGRF2	91	O14827
EIYQKAFDLIEHYFG	KPNA1	491	P52294
YFGDHIYSDLADLTL	NT5DC3	386	Q86UY8
YGYVLIEHLDFKHQS	FYB2	711	Q5VWT5
LYFDTKRYQEALHLG	PSMD11	136	O00231
SADLRALAKHLYDSY	PPARG	236	P37231
LGFYHEQSRTDRDDY	MEP1A	161	Q16819
KVFYHLGAFEESLNY	PSMD1	66	Q99460
KLYGDADYLEERHRH	CTPS1	466	P17812
LYRYDEISGKVEHFG	TENM2	2116	Q9NT68
NASVFKYYIHDLSDL	SRGAP2C	261	P0DJJ0
NASVFKYYIHDLSDL	SRGAP2B	261	P0DMP2
LEYKLHDFGYRGVSS	NAMPT	186	P43490
GFIEEIIHFKNYYDL	RNF216	301	Q9NWF9
EFAGDYVNALAHYEK	WDR19	786	Q8NEZ3
VLSEAHEGLYFLEAY	PKHD1	96	P08F94
EQFLTYHGHLYLRLD	SRCAP	2076	Q6ZRS2
YGLDDKLLHYNRSEE	SFR1	226	Q86XK3
ILFGEKYDHQRYQHT	ABCC12	561	Q96J65
YLEAHFGGADAARRY	TENT5B	326	Q96A09
YLQNHFAEEERSKYD	TENT5C	291	Q5VWP2
GLFAYHNIRVYDEET	SSH1	351	Q8WYL5
RYYFELLHKQDDRGS	B4GALNT4	241	Q76KP1
EELQGKHDVFTFYDY	AKAP6	1456	Q13023
FVGQEALYKYEALHL	ACTRT1	56	Q8TDG2
HTFEVYTEGERLYLF	ARAP1	816	Q96P48
DYKAGRVVEDLINHY	ARAP1	1121	Q96P48
HYIERFNELISLGEY	CLHC1	296	Q8NHS4
LHYAFQLYDLDRDGK	CHP2	116	O43745
LYQERYLADGDLHSD	CLSPN	1116	Q9HAW4
DYHYLRDSEAKANGL	ZCCHC2	141	Q9C0B9
DLKEVTHDLLYEGYR	SEPTIN1	281	Q8WYJ6
YGDKHITLYDIRAEL	SUPT6H	1116	Q7KZ85
QDKEFFGLRDYYSLI	RNF213	2946	Q63HN8
IHGDLYYEGKEFETR	SF3B2	586	Q13435
LYYFGERRTDKTHSE	TPTE	366	P56180
KDVLDSEGYLLFYHK	USP27X	406	A6NNY8
SEGYLLFYHKQVLEH	USP27X	411	A6NNY8
DVLDSEGYLLFYHKQ	USP22	506	Q9UPT9
DYDGKVFYIDHNTRR	WWC2	21	Q6AWC2
HHLRDYFEEYGKIDT	HNRNPA2B1	126	P22626
GLANDTDHYFLRYAV	PIGT	161	Q969N2
VRIYDLSKYDHGSDD	PPM1H	416	Q9ULR3
YEKALGYFHRAEQVD	RMDN1	241	Q96DB5
QHYLDSIKELYGAFA	SERPINA11	151	Q86U17
DRFEHELQKYRSFYG	SOGA3	551	Q5TF21
KYDGFDCVYGLELHR	SPIN3	86	Q5JUX0
FIKFDDDIHIYVYGL	SPIN4	231	Q56A73
HLYEDLFRARYNLGT	TONSL	196	Q96HA7
FEDEYSEYLKHNVRG	PPIL3	71	Q9H2H8
SRFAEALHYYKLAIG	TMTC2	541	Q8N394
NASVFKYYIHDLSDL	SRGAP2	261	O75044
RYSDFRKLHGDLAYT	SNX15	51	Q9NRS6
ALDRKGYNAREYYDH	PYGB	721	P11216
NIDYKHSFERFYHEE	TTC41P	261	Q6P2S7
GHKFDRDVELLIYYN	VWA5A	221	O00534
ELHDYFNVLSYRSLG	TIGIT	221	Q495A1
YGFKEEDYVIISHNF	PKHD1L1	2916	Q86WI1
AGLIKAFHEEYSRLY	USP28	796	Q96RU2
LYRAGVAFFHLQDYD	TTC9C	111	Q8N5M4
ADHYDNFRIYKALEA	MARS2	461	Q96GW9
SLYRYHFNGEELLFE	TRPM1	1271	Q7Z4N2
GDSFYIRTHFEYEKE	TJP1	516	Q07157
GLAAHYQKRHDIDAY	ZNF462	1711	Q96JM2
HKSFDENGFDYLLTY	STARD7	276	Q9NQZ5
GYFLEHNEAKYTERR	TAPT1	81	Q6NXT6
YHFEDTAGAYLLNRT	TM4SF5	126	O14894
YRHDLKIYASDEGRV	PPIP5K2	556	O43314
LYQYLQDLGHTDFEI	VEZT	16	Q9HBM0
TEEHHLRDYFEQYGK	HNRNPA1	116	P09651
LEFHASKIDELYEAY	RIPOR1	136	Q6ZS17
QNHFVGLEDRKYEYL	TENT5A	341	Q96IP4
RDYLGDFIEHYAQLG	PURA	111	Q00577
HYDRNKDGNKDVYLS	VPS39	726	Q96JC1
YTQGFFETEHLLKRY	UGT1A4	96	P22310
FHAFYQLLRGSEDKQ	MYO1G	201	B0I1T2
HVFYYLLAGASEDER	MYO9A	336	B2RTY4
LRIKEIHDGLDFYYS	NMD3	186	Q96D46